- Home
- KALA vs SAIH Comparison
KALA vs SAIH Comparison
Compare KALA & SAIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- SAIH
- Stock Information
- Founded
- KALA 2009
- SAIH 2019
- Country
- KALA United States
- SAIH Singapore
- Employees
- KALA 43
- SAIH N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- SAIH
- Sector
- KALA Health Care
- SAIH
- Exchange
- KALA Nasdaq
- SAIH NYSE
- Market Cap
- KALA 27.3M
- SAIH 27.3M
- IPO Year
- KALA 2017
- SAIH N/A
- Fundamental
- Price
- KALA $5.92
- SAIH $0.80
- Analyst Decision
- KALA Strong Buy
- SAIH
- Analyst Count
- KALA 2
- SAIH 0
- Target Price
- KALA $15.00
- SAIH N/A
- AVG Volume (30 Days)
- KALA 31.3K
- SAIH 143.3K
- Earning Date
- KALA 11-12-2024
- SAIH 12-31-2024
- Dividend Yield
- KALA N/A
- SAIH N/A
- EPS Growth
- KALA N/A
- SAIH N/A
- EPS
- KALA N/A
- SAIH N/A
- Revenue
- KALA N/A
- SAIH $6,954,000.00
- Revenue This Year
- KALA N/A
- SAIH N/A
- Revenue Next Year
- KALA N/A
- SAIH N/A
- P/E Ratio
- KALA N/A
- SAIH N/A
- Revenue Growth
- KALA N/A
- SAIH N/A
- 52 Week Low
- KALA $4.21
- SAIH $0.54
- 52 Week High
- KALA $9.25
- SAIH $1.80
- Technical
- Relative Strength Index (RSI)
- KALA 41.69
- SAIH N/A
- Support Level
- KALA $5.67
- SAIH N/A
- Resistance Level
- KALA $6.23
- SAIH N/A
- Average True Range (ATR)
- KALA 0.31
- SAIH 0.00
- MACD
- KALA -0.07
- SAIH 0.00
- Stochastic Oscillator
- KALA 21.55
- SAIH 0.00
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About SAIH SAIHEAT LIMITED
Saiheat Ltd develops technologies for the advanced Computing Center Ecosystem (ACCE), a next-gen computing center featuring high-performance servers, advanced liquid cooling, and systems for capturing and recycling computing heat. It aims to reduce the carbon footprint of Bitcoin mining and AI operations.